当前位置:首页 - 行情中心 - 艾德生物(300685) - 财务分析

艾德生物

(300685)

  

流通市值:83.06亿  总市值:84.11亿
流通股本:3.94亿   总股本:3.99亿

艾德生物(300685)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.64亿元,每股收益0.16元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益177158.01万元,未分配利润107105.14万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产197435.81万元,负债20277.80万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入233,288,808.061,043,506,694.32707,591,539.73458,706,418.67
营业总成本167,788,210.58743,673,780.47522,953,544.65325,528,824.4
营业利润74,947,564.69301,246,716.87196,604,196.93144,958,657.18
利润总额73,566,224.34294,857,124.56193,559,329.38143,602,741.94
净利润64,199,068.03261,484,433.37173,733,402.19126,761,239.87
其他综合收益-602,856.41-300,612.36545,061.37
综合收益总额64,199,068.03262,087,289.78173,432,789.83127,306,301.24
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计1,667,794,352.521,620,471,886.981,426,795,195.981,353,540,049.44
非流动资产合计306,563,748.45314,409,666.04341,109,876.11357,920,119.76
资产总计1,974,358,100.971,934,881,553.021,767,905,072.091,711,460,169.2
流动负债合计147,358,072.9174,476,692.16102,119,289.0892,680,114.78
非流动负债合计55,419,963.357,083,954.7859,115,529.3258,971,429.13
负债合计202,778,036.2231,560,646.94161,234,818.4151,651,543.91
归属于母公司股东权益合计1,771,580,064.771,703,320,906.081,606,670,253.691,559,808,625.29
股东权益合计1,771,580,064.771,703,320,906.081,606,670,253.691,559,808,625.29
负债和股东权益合计1,974,358,100.971,934,881,553.021,767,905,072.091,711,460,169.2
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计273,690,053.971,025,287,404.29747,397,660.25495,124,721.87
经营活动现金流出小计193,112,150.87726,571,533.88532,147,747.7352,145,343.27
经营活动产生的现金流量净额80,577,903.1298,715,870.41215,249,912.55142,979,378.6
投资活动现金流入小计200,315,491.43612,853,276.27456,108,397.39330,253,772.39
投资活动现金流出小计149,318,669.37944,847,181.79657,380,909.04433,508,330.96
投资活动产生的现金流量净额50,996,822.06-331,993,905.52-201,272,511.65-103,254,558.57
筹资活动现金流入小计-65,298,534.458,880,236.688,636,130
筹资活动现金流出小计6,264,821.6583,342,843.8382,060,458.2880,478,393.57
筹资活动产生的现金流量净额-6,264,821.65-18,044,309.38-73,180,221.6-71,842,263.57
汇率变动对现金及现金等价物的影响-2,637,585.638,808,751.1810,952,233.3316,073,402.24
现金及现金等价物净增加额122,672,317.88-42,513,593.31-48,250,587.37-16,044,041.3
期末现金及现金等价物余额323,750,184.55201,077,866.67195,340,872.61227,547,418.68
最新报告期:2024-04-23
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
中金公司府嘉颖0.760.92--2024-04-23
光大证券黎一江0.790.951.142024-04-23
国信证券张超,张佳博0.821.021.242024-04-22
光大证券黎一江0.790.951.142024-04-18
国泰君安丁丹,赵峻峰0.730.951.242024-04-18
TOP↑